Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP
- 15 July 2011
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (14), 4332-4336
- https://doi.org/10.1016/j.bmcl.2011.05.049
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Caspases, IAPs and Smac/DIABLO: mechanisms from structural biologyTrends in Biochemical Sciences, 2004
- Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarizationAnalytical Biochemistry, 2004
- Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of CancerJournal of Medicinal Chemistry, 2004
- Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activityCancer Cell, 2004
- Structural Basis for the Inhibition of Caspase-3 by XIAPCell, 2001
- Structural Basis of Caspase-7 Inhibition by XIAPCell, 2001
- Structural Basis of Caspase Inhibition by XIAPCell, 2001
- Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domainNature, 2000
- Apoptosis in cancerCarcinogenesis: Integrative Cancer Research, 2000
- IAP family proteins---suppressors of apoptosisGenes & Development, 1999